Journal of Clinical Microbiology, January 1999, p. 281-281, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Sequence-Based Classification Scheme for the Genus
Legionella Targeting the 5S rRNA Gene
 |
LETTER |
We read with interest the article by Ratcliff et al.
(3) concerning a sequence-based classification of
Legionella targeting the mip gene. We have used a
similar classification system based on the smaller 5S rRNA gene (104 bp) which, while less discriminatory than the mip gene,
enables species-specific identification of most Legionella
species implicated in human disease.
Our classification scheme was constructed from the 5S rRNA sequences of
type strains deposited in the GenBank database by Heidrich et al.
(1, 4) and others. All species in the database, including
eight species thus far isolated only from environmental sources, can be
distinguished from each other, apart from L. longbeachae serogroup 2, L. dumoffii, and L. hackeliae, which
have identical 5S rRNA sequences. Several other species exhibit
differences of only one or two bases. However, L. pneumophila is easily distinguished from other species by a
signature sequence at bp 61 to 63 (TTT). While the 5S rRNA genes of
many L. pneumophila strains have been sequenced, the
corresponding sequences for other species are currently based on only a
few strains.
We have used this scheme to identify both Legionella
isolates and Legionella DNA detected in urine and serum
samples by PCR using the following methods. DNA from bacterial isolates
was extracted by an alkaline lysis method, where 50 µl of bacterial
suspension (109 CFU/ml) was added to 50 µl of 0.05 M
NaOH, heated at 95°C for 15 min, and then neutralized by the addition
of 10 µl of 1 M Tris (pH 7.7). Urine (200 µl) and serum (100 µl)
samples were incubated in a 550-µl lysis solution containing 8.6 mM
Tris (pH 8.3), 1.1 mM EDTA, 0.01% (wt/vol) glycogen, 0.9% (wt/vol)
sodium dodecyl sulfate, and 0.45 mg of proteinase K/ml for 30 min at
56°C, and DNA was extracted with phenol and chloroform. The 5S rRNA
gene was amplified by PCR (2) with M13-tailed primers.
Products to be sequenced were purified by using a High Pure PCR Product Purification kit (Boehringer, Mannheim, Germany). Cycle sequencing reactions were performed by using a Thermo Sequenase
fluorescence-labelled primer cycle sequencing kit with 7-deaza-dGTP
(Amersham Life Science, Little Chalfont, United Kingdom) and
IRD-41-labelled infrared M13 forward and reverse primers. Sequencing
reaction products were analyzed on a LI-COR 4000L automated DNA
sequencer (LI-COR Inc., Lincoln, Nebr.).
We have tested cultures of the following species using these methods:
L. pneumophila serogroups 1 to 14, L. anisa,
L. israelensis, L. birminghamensis, L. micdadei, L. longbeachae serogroup 1, L. wadsworthii, L. oakridgensis, L. dumoffii,
L. jordanis, L. feelei serogroup 2, L. hackeliae, L. macearchernii, L. sainthelensi, and L. bozemanii serogroup 2. All results
confirmed identifications by conventional methods. Of the nine wild
strains tested (L. pneumophila [4],
L. longbeachae [2], L. bozemanii
[2], and L. feelei), the L. pneumophila strains showed 100% homology with the database, while
the other species exhibited one or two base differences. This approach
has also enabled us to identify to species level Legionella
DNA detected in urine and serum samples from patients with pneumonia
(unpublished data).
The 5S rRNA target has insufficient discriminatory power if genotyping
Legionella species is the primary goal. However, this scheme
may be useful for laboratories committed to a 5S rRNA PCR system,
especially for the differentiation of L. pneumophila from other species.
 |
ACKNOWLEDGMENTS |
We thank Luciano Matson, Aaron Jeffs, and the Cytogenetic and
Molecular Oncology Unit, Department of Pathology, Christchurch School
of Medicine, for assistance with sequencing.
Financial support was provided by a short-term study grant from the
Royal Australasian College of Physicians.
 |
FOOTNOTES |
*
Present address: Division of Infectious Diseases and
International Health, Box 3824, Duke University Medical Center, Durham, NC 27710. Phone: (919) 684-2660. Fax: (919) 684-8902. E-mail: murdo005{at}mc.duke.edu.
 |
REFERENCES |
| 1.
|
Heidrich, B.,
F. Tiecke,
P. N. Robinson,
D. Steinhoff,
F. J. Fehrenbach, and A. Rolfs.
1994.
Automated direct sequencing of Legionella 5S rDNA.
Med. Microbiol. Lett.
3:279-290.
|
| 2.
|
Murdoch, D. R.,
E. J. Walford,
L. C. Jennings,
G. J. Light,
M. I. Schousboe,
A. Y. Chereshsky,
S. T. Chambers, and G. I. Town.
1996.
Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia.
Clin. Infect. Dis.
23:475-480[Medline].
|
| 3.
|
Ratcliff, R. M.,
J. A. Lanser,
P. A. Manning, and M. W. Heuzenroeder.
1998.
Sequence-based classification scheme for the genus Legionella targeting the mip gene.
J. Clin. Microbiol.
36:1560-1567[Abstract/Free Full Text].
|
| 4.
|
Robinson, P. N.,
B. Heidrich,
F. Tiecke,
F. J. Fehrenbach, and A. Rolfs.
1996.
Species-specific detection of Legionella using polymerase chain reaction and reverse dot-blotting.
FEMS Microbiol. Lett.
140:111-119[Medline].
|
| | | | |
David R. Murdoch
Gillian J. Light
Lance C. Jennings
Microbiology Unit Canterbury Health Laboratories Christchurch, New Zealand
|
| | | | |
Stephen T. Chambers
Department of Infectious Diseases Christchurch Hospital Christchurch, New Zealand
|
Journal of Clinical Microbiology, January 1999, p. 281-281, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.